T1D Exchange’s Dara Schuster, MD Serves on Panel at BIO CEO Investor Conference

Posted on: January 7, 2019

Event Name: BIO CEO & Investor Conference; New Treatments for Diabetes and Obesity: Innovations for Chronic Diseases Panel

Date: February 12, 2019

Panel Description: BIO research on venture funding trends shows a long-term slowdown in overall investment in chronic diseases, despite their large patient populations, but with recent signs of hope in investor support for new treatments for diabetes and obesity. This session will detail those drug pipelines, which research approaches are convincing skeptical investors, as well as the sources of investor resistance, plus opportunities for streamlining high-cost clinical trials in these disease areas through application of digital technologies.

Organized by: Biotechnology Innovation Organization

Location: New York City, NY

T1D Exchange Attendees: Dara Schuster, MD

Link: https://www.bio.org/events/bio-ceo-investor-conference